You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

high risk adenocarcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC Trial in Boston (other, diagnostic test, combination product)

Not yet recruiting
  • Pancreatic Cancer
  • +4 more
  • Screening Blood Tests
  • +3 more
  • Boston, Massachusetts
  • +1 more
Nov 3, 2023

Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC Trial in Rochester (Bio-specimen Collection: Blood, Bio-specimen

Recruiting
  • Pancreatic Cancer
  • +3 more
  • Bio-specimen Collection: Blood
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Nov 21, 2023

Adenocarcinoma of the Prostate Trial in Montreal (Androgen suppression plus radiation therapy)

Active, not recruiting
  • Adenocarcinoma of the Prostate
  • Androgen suppression plus radiation therapy
  • Montreal, Quebec, Canada
  • +1 more
Jan 30, 2023

Prostate Adenocarcinoma Trial in Dallas (68-Ga PSMA11)

Not yet recruiting
  • Prostate Adenocarcinoma
  • 68-Ga PSMA11
  • Dallas, Texas
    UT Southwestern Medical Center
Sep 12, 2023

Gallbladder Adenocarcinoma Trial in Morgantown (HIPEC)

Not yet recruiting
  • Gallbladder Adenocarcinoma
  • Morgantown, West Virginia
    West Virginia University Cancer Institute Mary Babb Randolph Can
Jun 23, 2022

Panc CA Risk Model & Biomarker Testing In High-Risk Cohort

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • Blood Specimen
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Sep 5, 2022

Prostate Adenocarcinoma, Stage IIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage IIC Prostate Cancer AJCC

Recruiting
  • Prostate Adenocarcinoma
  • +7 more
  • High-Dose Rate Brachytherapy
  • Stereotactic Body Radiation Therapy
  • Los Angeles, California
    University of California at Los Angeles / Jonsson Comprehensive
Oct 13, 2022

Prostate Cancer, Prostate Adenocarcinoma Trial (drug, other, procedure)

Not yet recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • (no location specified)
Feb 2, 2023

Liquid Biopsies and Tumor Molecular Profiling in Predicting

Recruiting
  • Endometrial Clear Cell Adenocarcinoma
  • +5 more
  • Biospecimen Collection
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 3, 2022

Adenocarcinoma of the Pancreas, Adenocarcinoma of the Duodenum, Ampullary Adenocarcinoma Trial in Lille (total pancreatectomy,

Recruiting
  • Adenocarcinoma of the Pancreas
  • +2 more
  • total pancreatectomy
  • intraportal islet autotransplantation
  • Lille, France
    Hop Claude Huriez Chu Lille
Mar 14, 2022

Pancreas Cancer, Duct Cell Adenocarcinoma, Pancreas Adenocarcinoma, Peritoneal Metastases Trial in Quebec City (Whole-body

Recruiting
  • Pancreas Cancer, Duct Cell Adenocarcinoma
  • +3 more
  • Whole-body diffusion-weighted magnetic resonance imaging
  • Quebec City, Quebec, Canada
    CHU de Québec
Apr 20, 2022

Pancreas Cancer, Exosomes, Extracellular Vesicles Trial

Not yet recruiting
  • Pancreas Cancer
  • +3 more
    • (no location specified)
    Dec 6, 2022

    Prostate Cancer, BRCA1 Mutation, BRCA2 Mutation Trial (Olaparib, LHRH agonist)

    Not yet recruiting
    • Prostate Cancer
    • +4 more
    • (no location specified)
    Aug 10, 2022

    Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in United

    Active, not recruiting
    • Endometrial Clear Cell Adenocarcinoma
    • +4 more
    • Computed Tomography
    • +5 more
    • Houston, Texas
    • +6 more
    Dec 5, 2022

    Prostate Cancer, Prostate Cancer Adenocarcinoma, Non-Metastatic Trial in Durham (Cabozantinib, Radical Prostatectomy)

    Terminated
    Has Results
    • Prostate Cancer
    • +2 more
    • Durham, North Carolina
      Duke University Medical Center
    Jun 3, 2022

    Gastric Adenocarcinoma, Gastric Cancer Trial in Odense, Stockholm (Doxorubicin, Cisplatin)

    Completed
    • Gastric Adenocarcinoma
    • Gastric Cancer
    • Odense, Denmark
    • +1 more
    Oct 5, 2022

    Prostate Adenocarcinoma, Prostate Cancer, High Risk Prostate Cancer Trial in Baltimore, Boston, Seattle (Enzalutamide,

    Completed
    Has Results
    • Prostate Adenocarcinoma
    • +2 more
    • Baltimore, Maryland
    • +3 more
    Mar 30, 2022

    Prostate Cancer, Prostate Adenocarcinoma Trial in Netherlands

    Recruiting
    • Prostate Cancer
    • Prostate Adenocarcinoma
      • Alkmaar, Netherlands
      • +27 more
      Jun 27, 2023

      Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Scottsdale, Rochester

      Active, not recruiting
      • Prostate Adenocarcinoma
      • +5 more
      • Androgen Suppression
      • +3 more
      • Scottsdale, Arizona
      • +1 more
      Jan 5, 2023

      Stage I Prostate Adenocarcinoma American Joint Committee on Cancer (AJCC) v7, Stage II Prostate Adenocarcinoma AJCC v7, Stage

      Active, not recruiting
      Has Results
      • Stage I Prostate Adenocarcinoma American Joint Committee on Cancer (AJCC) v7
      • +2 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Los Angeles, California
        UCLA / Jonsson Comprehensive Cancer Center
      Dec 7, 2021

      Adenocarcinoma of the Prostate, Stage III Prostate Cancer Trial in Los Angeles (radiation, other, drug)

      Active, not recruiting
      • Adenocarcinoma of the Prostate
      • Stage III Prostate Cancer
      • stereotactic body radiation therapy
      • +3 more
      • Los Angeles, California
        Jonsson Comprehensive Cancer Center
      Apr 28, 2022

      Adenocarcinoma of the Colon Trial in London (Pembrolizumab)

      Recruiting
      • Adenocarcinoma of the Colon
      • London, United Kingdom
        University College Hospital
      Jul 20, 2022

      Stage II Prostate Adenocarcinoma, Stage III Prostate Adenocarcinoma Trial in Palo Alto (68Ga-PSMA-11, Magnetic resonance imaging

      Completed
      Has Results
      • Stage II Prostate Adenocarcinoma
      • Stage III Prostate Adenocarcinoma
      • Palo Alto, California
        Stanford University, School of Medicine
      Mar 2, 2022

      Adenocarcinoma of Prostate, Progression of Prostate Cancer Trial in Villejuif (Cabazitaxel, Pelvic radiotherapy, prostate

      Active, not recruiting
      • Adenocarcinoma of Prostate
      • Progression of Prostate Cancer
      • Villejuif, France
        Institut Gustave Roussy
      Oct 5, 2021

      Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial (Biospecimen Collection,

      Not yet recruiting
      • Prostate Adenocarcinoma
      • +2 more
      • Biospecimen Collection
      • +6 more
      • (no location specified)
      Mar 28, 2023